EditForce

EditForce develops drugs and seeds by using nucleic acid manipulation technologies.

Launch date

2015

Employees

Market cap

Enterprise valuation

Fukuoka Fukuoka Prefecture (HQ)

Date	Investors	Amount	Round
-	KDDI Open Innovation Fund SUCCESS	N/A	-
May 2015	N/A	JPY1.0m	Early VC
Sep 2015	N/A	JPY150m	Seed
Mar 2016*	UTEC - The University of Tokyo Edge Capital Partners Kisco	JPY175m	Series A
Apr 2017	N/A	JPY300m	Series A
Nov 2018	N/A	JPY241m	Series A
Mar 2019*	Itochu Technology Ventures Newton BioCapital Japan Science and Technology Agency QB Capital K4 Ventures KISCO	JPY870m	Series B
Jun 2021*	Global Brain Corporation Itochu Technology Ventures MP Healthcare Venture Management Newton BioCapital FFG Venture Business Partners UTEC - The University of Tokyo Edge Capital Partners	$11.8m	Series C
May 2023*	SMBC Venture Capital Fukuoka Jisho	JPY300m	Series D
Total Funding		CAD37.5m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about EditForce